
U.S. stocks ended the week higher, but Nvidia Corporation ($NVDA) stole the headlines after CEO Jensen Huang resigned amid growing scrutiny over his ties to a businesswoman suspected of links
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| STE | Steris | 255.72 | 0.64 | 0.25% |
| Name | Price | % Change | |
|---|---|---|---|
| $255.72 | +0.25% |

U.S. stocks ended the week higher, but Nvidia Corporation ($NVDA) stole the headlines after CEO Jensen Huang resigned amid growing scrutiny over his ties to a businesswoman suspected of links

Steris (($STE)) has held its Q2 earnings call. Read on for the main highlights of the call. STERIS delivered a broadly positive second-quarter performance, with strong revenue, earnings and Life

Notable gainers among liquid option names this morning include Applovin (APP) $412.40 +18.72, Keurig Dr Pepper (KDP) $36.68 +1.26, STERIS (STE) $261.91 +8.47, Texas Pacific Land Trust (TPL) $288.50 +7.32,

Jefferies upgraded Steris (STE) to Buy from Hold with a price target of $305, up from $232. The company offers a “steady” double-digit earnings grower below its average multiple with

Steris ( ($STE) ) just unveiled an announcement. On November 9, 2026, STERIS Irish FinCo Unlimited Company, a wholly owned subsidiary of STERIS plc, priced a $1.5 billion offering of

UBS analyst Patrick Wood raised the firm’s price target on Steris (STE) to $290 from $270 and keeps a Buy rating on the shares. Published first on TheFly – the

09:09 EST Steris (STE) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on

KeyBanc analyst Brett Fishbin raised the firm’s price target on Steris (STE) to $284 from $269 on higher estimates and multiple, while keeping an Overweight rating on the shares. The

Steris ( ($STE) ) has shared an update. On November 4, 2026, STERIS plc, STERIS Corporation, STERIS Limited and STERIS Irish FinCo entered a $1.6 billion revolving credit agreement with

Reports Q2 revenue $1.59B, consensus $1.56B. “We are pleased with our second quarter performance,” said Dan Carestio, President and CEO of STERIS (STE). “Life Sciences delivered particularly strong performance in
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 10, 2027TBA | $24.74B | $2.79 | $1.60B | 1.03 | 30.15 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.